1. A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346). (15th March 2019) Authors: Wallace, J L; Nagy, P; Feener, T; Allain, T; Ditrói, T; Vaughan, D; Muscara, M; de Nucci, G; Buret, A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗